Clinical Trials
Biopharmaceutical company gains early access to Dynepo oncology data
Published in Gene Therapy Weekly, October 14th, 2004
Dynepo is a gene-activated erythropoietin product for the treatment of anemia in cancer patients treated with chemotherapy.
TKT expects that top-line results of the clinical trial will be available in the first half of 2005. If the data are positive, TKT intends to file an amendment to the European Dynepo product license in order to expand its approved indication to include anemia associated with cancer chemotherapy.
In a March 2004...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-10-14)
More Articles from Gene Therapy Weekly
- Cancer Therapy
Short interfering RNA targeting survivin generates apoptosis in cancer cells - Genetic Disorders
Supplementation therapy bypasses defective genes by boosting alternate ones - Head and Neck Cancer
Topoisomerase inhibitors augment the effect of cancer gene therapy - Vascular Occlusion
Monocyte chemoattractant protein-1 gene inhibition thwarts in-stent restenosis - Vector Development
Polymer-coated adenoviral vectors offer bioavailability with less toxicity - Alzheimer Disease
Genomics company awarded grant to conduct Alzheimer genome study - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
